Acceleron to Webcast Presentation at 35th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN) a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases, today announced that Habib Dable, President and Chief Executive Officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 2:00 p.m. PST (5:00 p.m. EST) in San Francisco, California. The presentation will include a c